Russell Alan J
Edgewise Therapeutics, Inc. · Chief Scientific Officer
Russell Alan J is listed in filings as Chief Scientific Officer at Edgewise Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 13, 2025, including sale activity. Recent filings connect the profile to Edgewise Therapeutics, Inc. (EWTX). The current snapshot covers public activity from Aug 14, 2024 to Nov 13, 2025. Reported amounts are shown as $2.1M to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M100k shares | SellAug 26, 2025 | $14.60 | $38.19 | |
| $26k1.9k shares | SellAug 12, 2025 | $13.39 | $38.19 | |
| $26k1.6k shares | SellMay 2, 2025 | $16.45 | $38.19 | |
| $6k200 shares | SellMar 7, 2025 | $30.02 | $38.19 | |
| $36k1.2k shares | SellFeb 6, 2025 | $30.13 | $38.19 | |
| $241k8k shares | SellFeb 5, 2025 | $30.02 | $38.19 | |
| $3M100k shares | SellDec 30, 2024 | $27.37 | $38.19 | |
| $2M74.2k shares | SellSep 20, 2024 | $28.25 | $38.19 | |
| $24k815 shares | SellSep 20, 2024 | $29.51 | $38.19 |